Secobarbital-mediated Inactivation of Cytochrome P450 2B1 and Its Active Site Mutants

Secobarbital (SB) is a relatively selective mechanism-based inactivator of cytochrome P450 2B1, that partitions between epoxidation and heme and protein modification during its enzyme inactivation. The SB-2B1 heme adduct formed in situ in a functionally reconstituted system has been spectrally documented and structurally characterized as N-(5-(2-hydroxypropyl)-5-(1-methylbutyl)barbituric acid)protoporphyrin IX. The SB-protein modification has been localized to 2B1 peptide 277-323 corresponding to the active site helix I of cytochrome P450 101. The targeting of heme and this active site peptide suggests that the 2B1 active site topology could influence the course of its inactivation. To explore this possibility, the individual SB epoxidation, heme and protein modification, and corresponding molar partition ratios of the wild type and seven structural 2B1 mutants, site-directed at specific substrate recognition sites, and known to influence 2B1 catalysis were examined after Escherichia coli expression. These studies reveal that Thr-302 is critical for SB-mediated heme N-alkylation, whereas Val-367 is a critical determinant of 2B1 protein modification, and Val-363 is important for SB epoxidation. SB docking into a refined 2B1 homology model coupled with molecular dynamics analyses provide a logical rationale for these findings.

[1]  B. Kemper,et al.  A single amino acid substitution confers progesterone 6 beta-hydroxylase activity to rabbit cytochrome P450 2C3. , 1993, The Journal of biological chemistry.

[2]  I. Phillips,et al.  A rapid one-step purification of NADPH-cytochrome c (P-450) reductase from rat liver microsomes. , 1983, Analytical biochemistry.

[3]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[4]  P. Ortiz de Montellano,et al.  Topological mapping of the active sites of cytochromes P4502B1 and P4502B2 by in situ rearrangement of aryl-iron complexes. , 1992, Biochemistry.

[5]  C. Walsh,et al.  Phenobarbital-induced rat liver cytochrome P-450. Purification and characterization of two closely related isozymic forms. , 1982, The Journal of biological chemistry.

[6]  D. Nelson,et al.  On the membrane topology of vertebrate cytochrome P-450 proteins. , 1988, The Journal of biological chemistry.

[7]  M. Correia,et al.  Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal. , 1989, Molecular pharmacology.

[8]  Y Fujii-Kuriyama,et al.  Site-directed mutageneses of rat liver cytochrome P-450d: catalytic activities toward benzphetamine and 7-ethoxycoumarin. , 1989, Biochemistry.

[9]  P. Ortiz de Montellano,et al.  Mechanism of oxidation of pi bonds by cytochrome P-450. Electronic requirements of the transition state in the turnover of phenylacetylenes. , 1987, The Journal of biological chemistry.

[10]  E. F. Johnson.  Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesis. , 1992, Trends in pharmacological sciences.

[11]  J. Halpert,et al.  Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies. , 1995, Chemical research in toxicology.

[12]  C. Walsh.  Suicide substrates, mechanism-based enzyme inactivators: recent developments. , 1984, Annual review of biochemistry.

[13]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[14]  M. Correia,et al.  Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. , 1983, Annual review of pharmacology and toxicology.

[15]  M. Sternberg,et al.  A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificity. , 1991, Protein engineering.

[16]  P. Ortiz de Montellano,et al.  Cytochrome P-450 inactivation by 3-alkylsydnones. Mechanistic implications of N-alkyl and N-alkenyl heme adduct formation. , 1988, Biochemistry.

[17]  R. Ornstein,et al.  A 175‐psec molecular dynamics simulation of camphor‐bound cytochrome P‐450cam , 1991, Proteins.

[18]  R. Lindberg,et al.  Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue , 1989, Nature.

[19]  Mark D. Paulsen,et al.  Predicting the product specificity and coupling of cytochrome P450cam , 1992, J. Comput. Aided Mol. Des..

[20]  J. Halpert,et al.  Role of residue 478 as a determinant of the substrate specificity of cytochrome P450 2B1. , 1992, Biochemistry.

[21]  J. Halpert,et al.  Engineering of cytochrome P450 2B1 specificity. Conversion of an androgen 16 beta-hydroxylase to a 15 alpha-hydroxylase. , 1993, The Journal of biological chemistry.

[22]  J. Halpert,et al.  Role of Residue 363 and 206 in Conversion of Cytochrome P450 2B1 from a Steroid 16-Hydroxylase to a 15α-Hydroxylase , 1994 .

[23]  R. Ornstein,et al.  Application of 3-dimensional homology modeling of cytochrome P450 2B1 for interpretation of site-directed mutagenesis results. , 1994, Journal of biomolecular structure & dynamics.

[24]  A. Dexter,et al.  Transient Heme N-Alkylation of Chloroperoxidase by Terminal Alkenes and Alkynes , 1995 .

[25]  D. W. Parish,et al.  The influence of side chain modifications of the heme moiety on prosthetic acceptance and function of rat hepatic cytochrome P-450 and tryptophan pyrrolase. , 1986, Archives of biochemistry and biophysics.

[26]  J. Halpert,et al.  Site-directed mutagenesis as a tool for molecular modeling of cytochrome P450 2B1. , 1995, Biochemistry.

[27]  Y. Imai,et al.  Point mutations at threonine-301 modify substrate specificity of rabbit liver microsomal cytochromes P-450 (laurate (ω-1)-hydroxylase and testosterone 16α-hydroxylase) , 1989 .